Japanese | English

| Sitemap |

Investor Relations  |  Environmental and Social Report  |  about Eisai  |  Inquiry

Eisai Global Site Investor Relations Environmental and Social Report about Eisai Potential Suppliers Inquiry

Understanding Eisai Company Introduction Video Annual Report 2009 Environmental and Social Report 2009			News Release List January 20, 2010 Fully Human Monoclonal Anti-TNF- Antibody HUMIRA® Receives Approval as Japan's First Biological Agent for Psoriasis January 19, 2010 Eisai Group Contributes to Haiti Earthquake Relief Efforts January 14, 2010 Eisai Submits Application for Additional Indication of Anti-arrhythmic Agent Tambocor® Tablets for Tachyarrhythmia in Paediatric Patients in Japan
			What's New List February 3, 2010 IR “Third Quarter Financial Results Explanation for the Fiscal Year Ending March 31, 2010 [Webcast, Material]” February 2, 2010 IR “Third Quarter Financial Results for the Fiscal Year Ending March 31, 2010” January 29, 2010 Commitment & Passion for hhc “Access to Medicines”
			Information Eisai President & CEO Haruo Naito to Serve as President of the International Federation of Pharmaceutical Manufacturers & Associations (November 4, 2009) Corporate Governance Report updated (October 30, 2009)

Privacy Policy  |  Terms of Use  |  Accessibility